Investigation of hematologic findings related to brucellosis in Anatolian region

References

1. 1.↵
   1. Laine CG,
   2. Johnson VE,
   3. Scott HM,
   4. Arenas-Gamboa AM.

   Global estimate of human brucellosis incidence. Emerg Infect Dis 2023; 29: 1789–1797.

   OpenUrl
2. 2.↵
   1. Kaya S,
   2. Elaldi N,
   3. Deveci O,
   4. Eskazan AE,
   5. Bekcibasi M,
   6. Hosoglu S.

   Cytopenia in adult brucellosis patients. Indian J Med Res 2018; 147: 73–80.

   OpenUrl
3. 3.↵
   1. Yumuk Z,
   2. O’Callaghan D.

   Brucellosis in Turkey -- an overview. Int J Infect Dis 2012; 16: e228–e235.

   OpenUrlPubMed
4. 4.↵
   Ministry of Health of Republic of Turkey. Brucellosis statistics. [Updated 2017; accessed 2024 Mar 26]. Available from: https://hsgm.saglik.gov.tr/depo/birimler/zoonotik-ve-vektorel-hastaliklar-db/Dokumanlar/Istatistikler/Web-Bruselloz.jpg
5. 5.↵
   1. Al Dahouk S,
   2. Nöckler K.

   Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther 2011; 9: 833–845.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Qie C,
   2. Cui J,
   3. Liu Y,
   4. Li Y,
   5. Wu H,
   6. Mi Y.

   Epidemiological and clinical characteristics of bacteremic brucellosis. J Int Med Res 2020; 48: 300060520936829.

   OpenUrl
7. 7.↵
   1. Atluri VL,
   2. Xavier MN,
   3. de Jong MF,
   4. den Hartigh AB,
   5. Tsolis RM.

   Interactions of the human pathogenic Brucella species with their hosts. Annu Rev Microbiol 2011; 65: 523–541.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Öncel S.

   [Brucella infectıons: assessment and management]. J Health Sci Kocaeli Uni 2016; 2: 25–30. [In Turkish]

   OpenUrl
9. 9.↵
   1. Franco MP,
   2. Mulder M,
   3. Gilman RH,
   4. Smits HL.

   Human brucellosis. Lancet Infect Dis 2007; 7: 775–786.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Kefaloudi C,
    2. Mellou K,
    3. Dougas G,
    4. Vorou R,
    5. Mitrou K,
    6. Kontopidou F.

    Human brucellosis in Greece, 2005-2020: a persistent public health problem. Vector Borne Zoonotic Dis 2022; 22: 163–169.

    OpenUrl
11. 11.
    1. Amjadi O,
    2. Rafiei A,
    3. Mardani M,
    4. Zafari P,
    5. Zarifian A.

    A review of the immunopathogenesis of brucellosis. Infect Dis (Lond) 2019; 51: 321–333.

    OpenUrl
12. 12.↵
    1. Doganay M,
    2. Aygen B.

    Human brucellosis: an overview. Int J Infect Dis 2003; 7: 173–182.

    OpenUrlCrossRef
13. 13.↵
    1. Freire ML,
    2. Machado de Assis TS,
    3. Silva SN,
    4. Cota G.

    Diagnosis of human brucellosis: systematic review and meta-analysis. PLoS Negl Trop Dis 2024; 18: e0012030.

    OpenUrl
14. 14.↵
    1. Özlü C.

    Brucellosis from hematology perspective. Dent Med J – R 2022; 4: 72–78.

    OpenUrl
15. 15.↵
    1. Ozturk-Engin D,
    2. Erdem H,
    3. Gencer S,
    4. Kaya S,
    5. Baran AI,
    6. Batirel A, et al.

    Liver involvement in patients with brucellosis: results of the Marmara study. Eur J Clin Microbiol Infect Dis 2014; 33: 1253–1262.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Erdem H,
    2. Elaldi N,
    3. Ak O,
    4. Gulsun S,
    5. Tekin R,
    6. Ulug M, et al.

    Genitourinary brucellosis: results of a multicentric study. Clin Microbiol Infect 2014; 20: O847–O853.

    OpenUrl
17. 17.↵
    1. Buzgan T,
    2. Karahocagil MK,
    3. Irmak H,
    4. Baran AI,
    5. Karsen H,
    6. Evirgen O, et al.

    Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis 2010; 14: e469–e478.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Çalık Ş,
    2. Gökengin AD.

    Human brucellosis in Turkey: a review of the literature between 1990-2009. Turk J Med Sci 2011; 41: 549–555.

    OpenUrl
19. 19.↵
    1. Al-Eissa Y,
    2. Al-Nasser M.

    Haematological manifestations of childhood brucellosis. Infection 1993; 21: 23–26.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Karaman K,
    2. Akbayram S,
    3. Bayhan GI,
    4. Dogan M,
    5. Parlak M,
    6. Akbayram HT, et al.

    Hematologic findings in children with brucellosis: experiences of 622 patients in Eastern Turkey. J Pediatr Hematol Oncol 2016; 38: 463–466.

    OpenUrl
21. 21.↵
    1. Wareth G,
    2. Melzer F,
    3. Neubauer H.

    In Brucella: selective pressure may turn some genes on instead of default off position. Med Hypotheses 2017; 103: 29–31.

    OpenUrl
22. 22.↵
    1. Aygen B,
    2. Doğanay M,
    3. Sümerkan B,
    4. Yildiz O,
    5. Kayabaş Ü.

    Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Med Mal Infect 2002; 32: 485–493.

    OpenUrlCrossRefWeb of Science
23. 23.↵
    1. Dilek I,
    2. Durmuş A,
    3. Karahocagil MK,
    4. Akdeniz H,
    5. Karsen H,
    6. Baran AI, et al.

    Hematological complications in 787 cases of acute brucellosis in eastern Turkey. Turk J Med Sci 2008; 38: 421–424.

    OpenUrl
24. 24.↵
    1. Zheng R,
    2. Xie S,
    3. Lu X,
    4. Sun L,
    5. Zhou Y,
    6. Zhang Y, et al.

    A systematic review and meta-analysis of epidemiology and clinical manifestations of human brucellosis in China. Biomed Res Int 2018; 2018: 5712920.

    OpenUrl
25. 25.↵
    1. Shi C,
    2. Wang L,
    3. Lv D,
    4. Wang G,
    5. Mengist HM,
    6. Jin T, et al.

    Epidemiological, Clinical and laboratory characteristics of patients with Brucella infection in Anhui Province, China. Infect Drug Resist 2021; 14: 2741–2752.

    OpenUrl
26. 26.↵
    1. Bakr S,
    2. AlFattani A,
    3. Al-Nounou R,
    4. Bakshi N,
    5. Khogeer H,
    6. Alharbi M, et al.

    Hematologic reference intervals for healthy adult Saudis in Riyadh. Ann Saudi Med 2022; 42: 191–203.

    OpenUrl
27. 27.↵
    1. Moreno E,
    2. Barquero-Calvo E.

    The role of neutrophils in brucellosis. Microbiol Mol Biol Rev 2020; 84: e00048–e00020.

    OpenUrl
28. 28.↵
    1. Guler S,
    2. Kokoglu OF,
    3. Ucmak H,
    4. Gul M,
    5. Ozden S,
    6. Ozkan F.

    Human brucellosis in Turkey: different clinical presentations. J Infect Dev Ctries 2014; 8: 581–588.

    OpenUrl
29. 29.↵
    1. Jiang W,
    2. Chen J,
    3. Li Q,
    4. Jiang L,
    5. Huang Y,
    6. Lan Y, et al.

    Epidemiological characteristics, clinical manifestations and laboratory findings in 850 patients with brucellosis in Heilongjiang Province, China. BMC Infect Dis 2019; 19: 439.

    OpenUrlPubMed
30. 30.↵
    1. Jiao PF,
    2. Chu WL,
    3. Ren GF,
    4. Hou JN,
    5. Li YM,
    6. Xing LH.

    Expression of eosinophils be beneficial to early clinical diagnosis of brucellosis. Int J Clin Exp Med 2015; 8: 19491–19495.

    OpenUrl
31. 31.↵
    1. Mubaraki MA,
    2. Sharahili AI,
    3. Elshanat S,
    4. El-khadragy MF,
    5. Thagfan FA,
    6. Al-Megrin WA, et al.

    Biochemical and hematological markers as brucellosis indicators in the Najran region of Saudi Arabia. J King Saud Univ Sci 2022; 34: 102138.

    OpenUrl
32. 32.↵
    1. Sari I,
    2. Altuntas F,
    3. Hacioglu S,
    4. Kocyigit I,
    5. Sevinc A,
    6. Sacar S, et al.

    A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis. Am J Hematol 2008; 83: 334–339.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Otahbachi M,
    2. Simoni J,
    3. Simoni G,
    4. Moeller JF,
    5. Cevik C,
    6. Meyerrose GE, et al.

    Gender differences in platelet aggregation in healthy individuals. J Thromb Thrombolysis 2010; 30: 184–191.

    OpenUrlCrossRefPubMed